BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nickoloff BJ, Osborne BA, Miele L. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene. 2003;22:6598-6608. [PMID: 14528285 DOI: 10.1038/sj.onc.1206758] [Cited by in Crossref: 206] [Cited by in F6Publishing: 194] [Article Influence: 10.8] [Reference Citation Analysis]
Number Citing Articles
1 Liu YF, Qu GQ, Lu YM, Kong WM, Liu Y, Chen WX, Liao XH. Silencing of MAP4K4 by short hairpin RNA suppresses proliferation, induces G1 cell cycle arrest and induces apoptosis in gastric cancer cells. Mol Med Rep 2016;13:41-8. [PMID: 26549737 DOI: 10.3892/mmr.2015.4510] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
2 Lewis TB, Robison JE, Bastien R, Milash B, Boucher K, Samlowski WE, Leachman SA, Dirk Noyes R, Wittwer CT, Perreard L, Bernard PS. Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction. Cancer 2005;104:1678-86. [DOI: 10.1002/cncr.21372] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
3 Song LL, Peng Y, Yun J, Rizzo P, Chaturvedi V, Weijzen S, Kast WM, Stone PJ, Santos L, Loredo A, Lendahl U, Sonenshein G, Osborne B, Qin JZ, Pannuti A, Nickoloff BJ, Miele L. Notch-1 associates with IKKalpha and regulates IKK activity in cervical cancer cells. Oncogene 2008;27:5833-44. [PMID: 18560356 DOI: 10.1038/onc.2008.190] [Cited by in Crossref: 89] [Cited by in F6Publishing: 88] [Article Influence: 6.4] [Reference Citation Analysis]
4 Yao J, Duan L, Fan M, Wu X. γ-secretase inhibitors exerts antitumor activity via down-regulation of Notch and Nuclear factor kappa B in human tongue carcinoma cells. Oral Diseases 2007;13:555-63. [DOI: 10.1111/j.1601-0825.2006.01334.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
5 Marshall AD, Picchione F, Geltink RI, Grosveld GC. PAX3-FOXO1 induces up-regulation of Noxa sensitizing alveolar rhabdomyosarcoma cells to apoptosis. Neoplasia 2013;15:738-48. [PMID: 23814486 DOI: 10.1593/neo.121888] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
6 Ji X, Wang Z, Geamanu A, Sarkar FH, Gupta SV. Inhibition of cell growth and induction of apoptosis in non-small cell lung cancer cells by delta-tocotrienol is associated with notch-1 down-regulation. J Cell Biochem 2011;112:2773-83. [DOI: 10.1002/jcb.23184] [Cited by in Crossref: 64] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
7 Hao L, Rizzo P, Osipo C, Pannuti A, Wyatt D, Cheung LW, Sonenshein G, Osborne BA, Miele L. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells. Oncogene 2010;29:201-13. [PMID: 19838210 DOI: 10.1038/onc.2009.323] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 6.8] [Reference Citation Analysis]
8 Barse L, Bocchetta M. Non-small-cell lung carcinoma: role of the Notch signaling pathway. Lung Cancer (Auckl) 2015;6:43-53. [PMID: 28210150 DOI: 10.2147/LCTT.S60329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Wu J, Ji Z, Liu H, Liu Y, Han D, Shi C, Shi C, Wang C, Yang G, Chen X, Shen C, Li H, Bi Y, Zhang D, Zhao S. Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway. Toxicol Lett 2013;220:61-9. [PMID: 23542114 DOI: 10.1016/j.toxlet.2013.03.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
10 Prabhu VV, Allen JE, Hong B, Zhang S, Cheng H, El-Deiry WS. Therapeutic targeting of the p53 pathway in cancer stem cells. Expert Opin Ther Targets 2012;16:1161-74. [PMID: 22998602 DOI: 10.1517/14728222.2012.726985] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
11 Furukawa S, Kawasaki Y, Miyamoto M, Hiyoshi M, Kitayama J, Akiyama T. The miR-1-NOTCH3-Asef pathway is important for colorectal tumor cell migration. PLoS One. 2013;8:e80609. [PMID: 24244701 DOI: 10.1371/journal.pone.0080609] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
12 Yu H, Zhao X, Huang S, Jian L, Qian G, Ge S. Blocking Notch1 signaling by RNA interference can induce growth inhibition in HeLa cells. Int J Gynecol Cancer 2007;17:511-6. [PMID: 17309564 DOI: 10.1111/j.1525-1438.2007.00813.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
13 Abd El-Rhman RH, El-Naga RN, Gad AM, Tadros MG, Hassaneen SK. Dibenzazepine Attenuates Against Cisplatin-Induced Nephrotoxicity in Rats: Involvement of NOTCH Pathway. Front Pharmacol 2020;11:567852. [PMID: 33381027 DOI: 10.3389/fphar.2020.567852] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Dumont AG, Yang Y, Reynoso D, Katz D, Trent JC, Hughes DP. Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumors. Carcinogenesis. 2012;33:1674-1683. [PMID: 22764137 DOI: 10.1093/carcin/bgs221] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
15 Kumari M, Krishnamurthy PT, Pinduprolu SKSS, Sola P. DR-5 and DLL-4 mAb Functionalized SLNs of Gamma-Secretase Inhibitors- An Approach for TNBC Treatment. Adv Pharm Bull 2021;11:618-23. [PMID: 34888208 DOI: 10.34172/apb.2021.070] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Rodríguez Salas N, González González E, Gamallo Amat C. Breast cancer stem cell hypothesis: clinical relevance (answering breast cancer clinical features). Clin Transl Oncol 2010;12:395-400. [DOI: 10.1007/s12094-010-0526-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
17 Yamaguchi H, Chang SS, Hsu JL, Hung MC. Signaling cross-talk in the resistance to HER family receptor targeted therapy. Oncogene 2014;33:1073-81. [PMID: 23542173 DOI: 10.1038/onc.2013.74] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 7.8] [Reference Citation Analysis]
18 Funahashi Y, Hernandez SL, Das I, Ahn A, Huang J, Vorontchikhina M, Sharma A, Kanamaru E, Borisenko V, Desilva DM, Suzuki A, Wang X, Shawber CJ, Kandel JJ, Yamashiro DJ, Kitajewski J. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis. Cancer Res. 2008;68:4727-4735. [PMID: 18559519 DOI: 10.1158/0008-5472.can-07-6499] [Cited by in Crossref: 114] [Cited by in F6Publishing: 74] [Article Influence: 8.1] [Reference Citation Analysis]
19 Qiu XW, Yu CH. Advances in understanding the relationship between liver cancer stem cells and metastasis and relapse of liver cancer. Shijie Huaren Xiaohua Zazhi 2011; 19(17): 1802-1807 [DOI: 10.11569/wcjd.v19.i17.1802] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Zarone MR, Misso G, Grimaldi A, Zappavigna S, Russo M, Amler E, Di Martino MT, Amodio N, Tagliaferri P, Tassone P, Caraglia M. Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment. Sci Rep 2017;7:17949. [PMID: 29263373 DOI: 10.1038/s41598-017-18186-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
21 Nickoloff BJ, Hendrix MJ, Pollock PM, Trent JM, Miele L, Qin JZ. Notch and NOXA-related pathways in melanoma cells. J Investig Dermatol Symp Proc 2005;10:95-104. [PMID: 16363061 DOI: 10.1111/j.1087-0024.2005.200404.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
22 Hopfer O, Zwahlen D, Fey MF, Aebi S. The Notch pathway in ovarian carcinomas and adenomas. Br J Cancer 2005;93:709-18. [PMID: 16136053 DOI: 10.1038/sj.bjc.6602719] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 4.6] [Reference Citation Analysis]
23 Spaner DE. Amplifying cancer vaccine responses by modifying pathogenic gene programs in tumor cells. Journal of Leukocyte Biology 2004;76:338-51. [DOI: 10.1189/jlb.0104016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
24 Hai L, Zhang C, Li T, Zhou X, Liu B, Li S, Zhu M, Lin Y, Yu S, Zhang K, Ren B, Ming H, Huang Y, Chen L, Zhao P, Zhou H, Jiang T, Yang X. Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway. Cell Death Dis 2018;9:158. [PMID: 29410396 DOI: 10.1038/s41419-017-0119-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
25 Olsauskas-Kuprys R, Zlobin A, Osipo C. Gamma secretase inhibitors of Notch signaling. Onco Targets Ther 2013;6:943-55. [PMID: 23901284 DOI: 10.2147/OTT.S33766] [Cited by in Crossref: 27] [Cited by in F6Publishing: 67] [Article Influence: 3.0] [Reference Citation Analysis]
26 Liu J, Liu S, Deng X, Rao J, Huang K, Xu G, Wang X. MicroRNA-582-5p suppresses non-small cell lung cancer cells growth and invasion via downregulating NOTCH1. PLoS One 2019;14:e0217652. [PMID: 31170211 DOI: 10.1371/journal.pone.0217652] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
27 Khan IS, Ehtesham M. Targeting glioblastoma cancer stem cells: the next great hope? Neurosurg Focus 2014;37:E7. [PMID: 25581936 DOI: 10.3171/2014.9.focus14509] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
28 Dill MT, Tornillo L, Fritzius T, Terracciano L, Semela D, Bettler B, Heim MH, Tchorz JS. Constitutive Notch2 signaling induces hepatic tumors in mice. Hepatology. 2013;57:1607-1619. [PMID: 23175466 DOI: 10.1002/hep.26165] [Cited by in Crossref: 87] [Cited by in F6Publishing: 131] [Article Influence: 9.7] [Reference Citation Analysis]
29 Lou I, Odorico S, Yu XM, Harrison A, Jaskula-Sztul R, Chen H. Notch3 as a novel therapeutic target in metastatic medullary thyroid cancer. Surgery 2018;163:104-11. [PMID: 29128180 DOI: 10.1016/j.surg.2017.07.039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
30 Yao J, Qian C. Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway. Med Oncol. 2010;27:1017-1022. [PMID: 19816816 DOI: 10.1007/s12032-009-9326-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
31 Schouwey K, Delmas V, Larue L, Zimber-Strobl U, Strobl LJ, Radtke F, Beermann F. Notch1 and Notch2 receptors influence progressive hair graying in a dose-dependent manner. Dev Dyn 2007;236:282-9. [PMID: 17080428 DOI: 10.1002/dvdy.21000] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 5.9] [Reference Citation Analysis]
32 Xu Y, Xu S, Cai Y, Liu L. Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1. Evid Based Complement Alternat Med 2015;2015:145016. [PMID: 26783407 DOI: 10.1155/2015/145016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
33 Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. Int J Cancer. 2006;118:1930-1936. [PMID: 16284950 DOI: 10.1002/ijc.21589] [Cited by in Crossref: 95] [Cited by in F6Publishing: 87] [Article Influence: 5.9] [Reference Citation Analysis]
34 Crosetto N, Tikkanen R, Dikic I. Oncogenic breakdowns in endocytic adaptor proteins. FEBS Letters 2005;579:3231-8. [DOI: 10.1016/j.febslet.2005.03.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
35 Neradugomma NK, Subramaniam D, Tawfik OW, Goffin V, Kumar TR, Jensen RA, Anant S. Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner. Carcinogenesis 2014;35:795-806. [PMID: 24265293 DOI: 10.1093/carcin/bgt379] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
36 Hansson EM, Lendahl U, Chapman G. Notch signaling in development and disease. Semin Cancer Biol. 2004;14:320-328. [PMID: 15288257 DOI: 10.1016/j.semcancer.2004.04.011] [Cited by in Crossref: 158] [Cited by in F6Publishing: 145] [Article Influence: 9.3] [Reference Citation Analysis]
37 Larsen JE, Minna JD. Molecular biology of lung cancer: clinical implications. Clin Chest Med. 2011;32:703-740. [PMID: 22054881 DOI: 10.1016/j.ccm.2011.08.003] [Cited by in Crossref: 126] [Cited by in F6Publishing: 112] [Article Influence: 11.5] [Reference Citation Analysis]
38 Hayward S. Viral interactions with the Notch pathway. Seminars in Cancer Biology 2004;14:387-96. [DOI: 10.1016/j.semcancer.2004.04.018] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 3.9] [Reference Citation Analysis]
39 Lee LA, Farris AD. Photosensitivity Diseases: Cutaneous Lupus Erythematosus. Journal of Investigative Dermatology Symposium Proceedings 1999;4:73-8. [DOI: 10.1038/sj.jidsp.5640186] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
40 Lindsay J, Jiao X, Sakamaki T, Casimiro MC, Shirley LA, Tran TH, Ju X, Liu M, Li Z, Wang C, Katiyar S, Rao M, Allen KG, Glazer RI, Ge C, Stanley P, Lisanti MP, Rui H, Pestell RG. ErbB2 induces Notch1 activity and function in breast cancer cells. Clin Transl Sci 2008;1:107-15. [PMID: 20443831 DOI: 10.1111/j.1752-8062.2008.00041.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
41 Noh HS, Hah YS, Ha JH, Kang MY, Zada S, Rha SY, Kang SS, Kim HJ, Park JY, Byun JH, Hahm JR, Shin JK, Jeong SH, Lee YJ, Kim DR. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity. Oncotarget 2016;7:4632-46. [PMID: 26716415 DOI: 10.18632/oncotarget.6728] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
42 Houde C, Li Y, Song L, Barton K, Zhang Q, Godwin J, Nand S, Toor A, Alkan S, Smadja NV, Avet-Loiseau H, Lima CS, Miele L, Coignet LJ. Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Blood 2004;104:3697-704. [PMID: 15292061 DOI: 10.1182/blood-2003-12-4114] [Cited by in Crossref: 120] [Cited by in F6Publishing: 108] [Article Influence: 6.7] [Reference Citation Analysis]
43 Giovannini C, Gramantieri L, Chieco P, Minguzzi M, Lago F, Pianetti S, Ramazzotti E, Marcu KB, Bolondi L. Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism. J Hepatol. 2009;50:969-979. [PMID: 19304334 DOI: 10.1016/j.jhep.2008.12.032] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
44 Nagao H, Setoguchi T, Kitamoto S, Ishidou Y, Nagano S, Yokouchi M, Abematsu M, Kawabata N, Maeda S, Yonezawa S, Komiya S. RBPJ is a novel target for rhabdomyosarcoma therapy. PLoS One 2012;7:e39268. [PMID: 22792167 DOI: 10.1371/journal.pone.0039268] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
45 Zhang P, Yang Y, Zweidler-McKay PA, Hughes DP. Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin Cancer Res 2008;14:2962-9. [PMID: 18483362 DOI: 10.1158/1078-0432.CCR-07-1992] [Cited by in Crossref: 114] [Cited by in F6Publishing: 58] [Article Influence: 8.1] [Reference Citation Analysis]
46 Lee SM, Jung CK, Ko YH, Choi JY, Lee KY, Kang CS. Expression of Notch 1 and 3 is related to inhibition of lymph node metastasis and progression in non-small cell lung carcinomas. Basic and Applied Pathology 2008;1:93-7. [DOI: 10.1111/j.1755-9294.2008.00020.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
47 Lee SH, Jeong EG, Yoo NJ, Lee SH. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. APMIS. 2007;115:1357-1363. [PMID: 18184405 DOI: 10.1111/j.1600-0463.2007.00751.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
48 Lee JM, Lee KH, Farrell CJ, Ling PD, Kempkes B, Park JH, Hayward SD. EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. J Virol 2004;78:12694-7. [PMID: 15507659 DOI: 10.1128/JVI.78.22.12694-12697.2004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
49 Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer. 2006;106:2503-2513. [PMID: 16628653 DOI: 10.1002/cncr.21904] [Cited by in Crossref: 188] [Cited by in F6Publishing: 181] [Article Influence: 11.8] [Reference Citation Analysis]
50 Kitamura T, Kitamura YI, Funahashi Y, Shawber CJ, Castrillon DH, Kollipara R, DePinho RA, Kitajewski J, Accili D. A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J Clin Invest 2007;117:2477-85. [PMID: 17717603 DOI: 10.1172/JCI32054] [Cited by in Crossref: 187] [Cited by in F6Publishing: 135] [Article Influence: 12.5] [Reference Citation Analysis]
51 Schmuck R, Warneke V, Behrens HM, Simon E, Weichert W, Röcken C. Genotypic and phenotypic characterization of side population of gastric cancer cell lines. Am J Pathol. 2011;178:1792-1804. [PMID: 21435459 DOI: 10.1016/j.ajpath.2010.12.043] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
52 Zheng X, Pang B, Gu G, Gao T, Zhang R, Pang Q, Liu Q. Melatonin Inhibits Glioblastoma Stem-like cells through Suppression of EZH2-NOTCH1 Signaling Axis. Int J Biol Sci 2017;13:245-53. [PMID: 28255276 DOI: 10.7150/ijbs.16818] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
53 Shi W, Harris AL. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials. J Mammary Gland Biol Neoplasia. 2006;11:41-52. [PMID: 16947085 DOI: 10.1007/s10911-006-9011-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
54 Taleb S, Abbaszadegan MR, Moghbeli M, Roudbari NH, Forghanifard MM. HES1 as an Independent Prognostic Marker in Esophageal Squamous Cell Carcinoma. J Gastrointest Canc 2014;45:466-71. [DOI: 10.1007/s12029-014-9648-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
55 Muller J, Chevrier L, Cochaud S, Meunier A, Chadeneau C. Hedgehog, Notch and Wnt developmental pathways as targets for anti-cancer drugs. Drug Discovery Today: Disease Mechanisms 2007;4:285-91. [DOI: 10.1016/j.ddmec.2008.05.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
56 Weli SC, Fink T, Cetinkaya C, Prasad MS, Pennisi CP, Zachar V. Notch and hedgehog signaling cooperate to maintain self-renewal of human embryonic stem cells exposed to low oxygen concentration. Int J Stem Cells 2010;3:129-37. [PMID: 24855550 DOI: 10.15283/ijsc.2010.3.2.129] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
57 Wang J, Wang C, Meng Q, Li S, Sun X, Bo Y, Yao W. siRNA targeting Notch-1 decreases glioma stem cell proliferation and tumor growth. Mol Biol Rep. 2012;39:2497-2503. [PMID: 21667253 DOI: 10.1007/s11033-011-1001-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
58 Coppock HA, Clarke RB. Mammary stem cells: the root of breast cancer? Breast Cancer Online 2004;7. [DOI: 10.1017/s1470903104001324] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
59 González-Moles MA, Scully C, Ruiz-Ávila I, Plaza-Campillo JJ. The cancer stem cell hypothesis applied to oral carcinoma. Oral Oncol 2013;49:738-46. [PMID: 23642758 DOI: 10.1016/j.oraloncology.2013.04.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
60 Xu F, Zhang ZQ, Fang YC, Li XL, Sun Y, Xiong CZ, Yan LQ, Wang Q. Metastasis-associated lung adenocarcinoma transcript 1 promotes the proliferation of chondrosarcoma cell via activating Notch-1 signaling pathway. Onco Targets Ther 2016;9:2143-51. [PMID: 27110130 DOI: 10.2147/OTT.S100003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
61 Liu J, Fukunaga-Kalabis M, Li L, Herlyn M. Developmental pathways activated in melanocytes and melanoma. Arch Biochem Biophys 2014;563:13-21. [PMID: 25109840 DOI: 10.1016/j.abb.2014.07.023] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 6.8] [Reference Citation Analysis]
62 Yavropoulou MP, Yovos JG. The role of Notch signaling in bone development and disease. Hormones (Athens) 2014;13:24-37. [PMID: 24722125 DOI: 10.1007/BF03401318] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
63 Ochieng J, Nangami GN, Ogunkua O, Miousse IR, Koturbash I, Odero-Marah V, McCawley LJ, Nangia-Makker P, Ahmed N, Luqmani Y, Chen Z, Papagerakis S, Wolf GT, Dong C, Zhou BP, Brown DG, Colacci AM, Hamid RA, Mondello C, Raju J, Ryan EP, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A, Al-Temaimi R, Al-Mulla F, Bisson WH, Eltom SE. The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis. Carcinogenesis 2015;36 Suppl 1:S128-59. [PMID: 26106135 DOI: 10.1093/carcin/bgv034] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
64 Takeuchi T, Adachi Y, Sonobe H, Furihata M, Ohtsuki Y. A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion. Oncogene 2006;25:7059-69. [PMID: 16715130 DOI: 10.1038/sj.onc.1209688] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
65 Roma J, Almazán-Moga A, Sánchez de Toledo J, Gallego S. Notch, wnt, and hedgehog pathways in rhabdomyosarcoma: from single pathways to an integrated network. Sarcoma 2012;2012:695603. [PMID: 22550422 DOI: 10.1155/2012/695603] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
66 Aste-Amézaga M, Zhang N, Lineberger JE, Arnold BA, Toner TJ, Gu M, Huang L, Vitelli S, Vo KT, Haytko P, Zhao JZ, Baleydier F, L'Heureux S, Wang H, Gordon WR, Thoryk E, Andrawes MB, Tiyanont K, Stegmaier K, Roti G, Ross KN, Franlin LL, Wang H, Wang F, Chastain M, Bett AJ, Audoly LP, Aster JC, Blacklow SC, Huber HE. Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors. PLoS One 2010;5:e9094. [PMID: 20161710 DOI: 10.1371/journal.pone.0009094] [Cited by in Crossref: 127] [Cited by in F6Publishing: 114] [Article Influence: 10.6] [Reference Citation Analysis]
67 Kang H, An HJ, Song JY, Kim TH, Heo JH, Ahn DH, Kim G. Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression. Histopathology. 2012;61:576-586. [PMID: 22691042 DOI: 10.1111/j.1365-2559.2012.04274.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
68 Kimura K, Satoh K, Kanno A, Hamada S, Hirota M, Endoh M, Masamune A, Shimosegawa T. Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice. Cancer Science 2007;98:155-62. [DOI: 10.1111/j.1349-7006.2006.00369.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
69 Pagliaro L, Sorrentino C, Roti G. Targeting Notch Trafficking and Processing in Cancers. Cells 2020;9:E2212. [PMID: 33003595 DOI: 10.3390/cells9102212] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
70 Huang M, Zhu H, Feng J, Ni S, Huang J. High CD133 expression in the nucleus and cytoplasm predicts poor prognosis in non-small cell lung cancer. Dis Markers 2015;2015:986095. [PMID: 25691807 DOI: 10.1155/2015/986095] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
71 Zou W, Chen QX, Sun XW, Chi QB, Kuang HY, Yu XP, Dai XH. Acupuncture inhibits Notch1 and Hes1 protein expression in the basal ganglia of rats with cerebral hemorrhage. Neural Regen Res 2015;10:457-62. [PMID: 25878596 DOI: 10.4103/1673-5374.153696] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
72 Yoon SS, Segal NH, Park PJ, Detwiller KY, Fernando NT, Ryeom SW, Brennan MF, Singer S. Angiogenic Profile of Soft Tissue Sarcomas Based on Analysis of Circulating Factors and Microarray Gene Expression. Journal of Surgical Research 2006;135:282-90. [DOI: 10.1016/j.jss.2006.01.023] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
73 Wang M, Wu L, Wang L, Xin X. Down-regulation of Notch1 by gamma-secretase inhibition contributes to cell growth inhibition and apoptosis in ovarian cancer cells A2780. Biochem Biophys Res Commun. 2010;393:144-149. [PMID: 20117093 DOI: 10.1016/j.bbrc.2010.01.103] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
74 Cheung HC, Corley LJ, Fuller GN, McCutcheon IE, Cote GJ. Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma. Mod Pathol 2006;19:1034-41. [PMID: 16729017 DOI: 10.1038/modpathol.3800635] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
75 Rosati E, Sabatini R, Rampino G, Tabilio A, Di Ianni M, Fettucciari K, Bartoli A, Coaccioli S, Screpanti I, Marconi P. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood 2009;113:856-65. [PMID: 18796623 DOI: 10.1182/blood-2008-02-139725] [Cited by in Crossref: 203] [Cited by in F6Publishing: 190] [Article Influence: 14.5] [Reference Citation Analysis]
76 Balint K, Xiao M, Pinnix CC, Soma A, Veres I, Juhasz I, Brown EJ, Capobianco AJ, Herlyn M, Liu ZJ. Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest 2005;115:3166-76. [PMID: 16239965 DOI: 10.1172/JCI25001] [Cited by in Crossref: 244] [Cited by in F6Publishing: 135] [Article Influence: 14.4] [Reference Citation Analysis]
77 Harris Z, Donovan MG, Branco GM, Limesand KH, Burd R. Quercetin as an Emerging Anti-Melanoma Agent: A Four-Focus Area Therapeutic Development Strategy. Front Nutr 2016;3:48. [PMID: 27843913 DOI: 10.3389/fnut.2016.00048] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
78 Rodrigues C, Joy LR, Sachithanandan SP, Krishna S. Notch signalling in cervical cancer. Exp Cell Res 2019;385:111682. [PMID: 31634483 DOI: 10.1016/j.yexcr.2019.111682] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
79 Leong KG, Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood. 2006;107:2223-2233. [PMID: 16291593 DOI: 10.1182/blood-2005-08-3329] [Cited by in Crossref: 364] [Cited by in F6Publishing: 328] [Article Influence: 21.4] [Reference Citation Analysis]
80 Qiao L, Wong BC. Role of Notch signaling in colorectal cancer. Carcinogenesis. 2009;30:1979-1986. [PMID: 19793799 DOI: 10.1093/carcin/bgp236] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 7.3] [Reference Citation Analysis]
81 Sjölund J, Manetopoulos C, Stockhausen MT, Axelson H. The Notch pathway in cancer: differentiation gone awry. Eur J Cancer. 2005;41:2620-2629. [PMID: 16239105 DOI: 10.1016/j.ejca.2005.06.025] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 5.2] [Reference Citation Analysis]
82 Bonini SA, Ferrari-Toninelli G, Montinaro M, Memo M. Notch signalling in adult neurons: a potential target for microtubule stabilization. Ther Adv Neurol Disord 2013;6:375-85. [PMID: 24228073 DOI: 10.1177/1756285613490051] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
83 Tysnes BB. Tumor-initiating and -propagating cells: cells that we would like to identify and control. Neoplasia 2010;12:506-15. [PMID: 20651980 DOI: 10.1593/neo.10290] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
84 Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC, Chintagumpala M, Adesina A, Ashley DM, Kellie SJ, Taylor MD, Curran T, Gajjar A, Gilbertson RJ. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 2006;24:1924-31. [PMID: 16567768 DOI: 10.1200/JCO.2005.04.4974] [Cited by in Crossref: 502] [Cited by in F6Publishing: 274] [Article Influence: 31.4] [Reference Citation Analysis]
85 Sweeney C, Morrow D, Birney YA, Coyle S, Hennessy C, Scheller A, Cummins PM, Walls D, Redmond EM, Cahill PA. Notch 1 and 3 receptors modulate vascular smooth muscle cell growth, apoptosis and migration via a CBF‐1/RBP‐Jk dependent pathway. FASEB j 2004;18:1421-3. [DOI: 10.1096/fj.04-1700fje] [Cited by in Crossref: 99] [Cited by in F6Publishing: 98] [Article Influence: 5.5] [Reference Citation Analysis]
86 Mullendore ME, Koorstra JB, Li YM, Offerhaus GJ, Fan X, Henderson CM, Matsui W, Eberhart CG, Maitra A, Feldmann G. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clin Cancer Res. 2009;15:2291-2301. [PMID: 19258443 DOI: 10.1158/1078-0432.ccr-08-2004] [Cited by in Crossref: 126] [Cited by in F6Publishing: 85] [Article Influence: 9.7] [Reference Citation Analysis]
87 Izrailit J, Reedijk M. Developmental pathways in breast cancer and breast tumor-initiating cells: Therapeutic implications. Cancer Letters 2012;317:115-26. [DOI: 10.1016/j.canlet.2011.11.028] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
88 Carlson JA, Linette GP, Aplin A, Ng B, Slominski A. Melanocyte receptors: clinical implications and therapeutic relevance. Dermatol Clin 2007;25:541-57, viii-ix. [PMID: 17903613 DOI: 10.1016/j.det.2007.06.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
89 Lewis HD, Leveridge M, Strack PR, Haldon CD, O'neil J, Kim H, Madin A, Hannam JC, Look AT, Kohl N, Draetta G, Harrison T, Kerby JA, Shearman MS, Beher D. Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling. Chem Biol. 2007;14:209-219. [PMID: 17317574 DOI: 10.1016/j.chembiol.2006.12.010] [Cited by in Crossref: 108] [Cited by in F6Publishing: 95] [Article Influence: 7.2] [Reference Citation Analysis]
90 Zhang Y, Lam O, Nguyen MT, Ng G, Pear WS, Ai W, Wang IJ, Kao WW, Liu CY. Mastermind-like transcriptional co-activator-mediated Notch signaling is indispensable for maintaining conjunctival epithelial identity. Development 2013;140:594-605. [PMID: 23293291 DOI: 10.1242/dev.082842] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
91 Hübscher SG, Strain AJ. Another Notch to be added to the list of hepatocellular growth regulatory factors? Hepatology 2005;41:439-42. [DOI: 10.1002/hep.20640] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
92 Yong T, Sun A, Henry MD, Meyers S, Davis JN. Down regulation of CSL activity inhibits cell proliferation in prostate and breast cancer cells. J Cell Biochem. 2011;112:2340-2351. [PMID: 21520243 DOI: 10.1002/jcb.23157] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
93 Chen HF, Wu KJ. Endothelial Transdifferentiation of Tumor Cells Triggered by the Twist1-Jagged1-KLF4 Axis: Relationship between Cancer Stemness and Angiogenesis. Stem Cells Int 2016;2016:6439864. [PMID: 26823670 DOI: 10.1155/2016/6439864] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
94 Li M, Chen F, Clifton N, Sullivan DM, Dalton WS, Gabrilovich DI, Nefedova Y. Combined inhibition of Notch signaling and Bcl-2/Bcl-xL results in synergistic antimyeloma effect. Mol Cancer Ther. 2010;9:3200-3209. [PMID: 21159606 DOI: 10.1158/1535-7163.mct-10-0372] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
95 Lee M, Kim M, Mo J, Ann E, Seo M, Hong J, Kim Y, Park H. Indirubin-3′-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling. Cancer Letters 2008;265:215-25. [DOI: 10.1016/j.canlet.2008.02.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
96 Zaravinos A, Bonavida B, Chatzaki E, Baritaki S. RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact. Cancers (Basel) 2018;10:E287. [PMID: 30149591 DOI: 10.3390/cancers10090287] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 7.8] [Reference Citation Analysis]
97 Xu Z, Xu L, Wang J, Mang J, Yang L, He J. Expression changes of the notch signaling pathway of PC12 cells after oxygen glucose deprivation. International Journal of Biological Macromolecules 2018;118:1984-8. [DOI: 10.1016/j.ijbiomac.2018.07.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
98 Zhao J, Wang Y, Mu C, Xu Y, Sang J. MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells. Oncogene 2017;36:5023-34. [DOI: 10.1038/onc.2017.131] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
99 Speiser J, Foreman K, Drinka E, Godellas C, Perez C, Salhadar A, Erşahin Ç, Rajan P. Notch-1 and Notch-4 biomarker expression in triple-negative breast cancer. Int J Surg Pathol 2012;20:139-45. [PMID: 22084425 DOI: 10.1177/1066896911427035] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
100 Ishii T, Yasuchika K, Suemori H, Nakatsuji N, Ikai I, Uemoto S. Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma. Cancer Lett. 2010;294:25-34. [PMID: 20149523 DOI: 10.1016/j.canlet.2010.01.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
101 Maitra A, Hruban RH. Pancreatic cancer. Annu Rev Pathol. 2008;3:157-188. [PMID: 18039136 DOI: 10.1146/annurev.pathmechdis.3.121806.154305] [Cited by in Crossref: 489] [Cited by in F6Publishing: 450] [Article Influence: 34.9] [Reference Citation Analysis]
102 Shao S, Zhao X, Zhang X, Luo M, Zuo X, Huang S, Wang Y, Gu S, Zhao X. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Mol Cancer 2015;14:28. [PMID: 25645291 DOI: 10.1186/s12943-015-0295-3] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 15.0] [Reference Citation Analysis]
103 Wang AM, Ku HH, Liang YC, Chen YC, Hwu YM, Yeh TS. The autonomous notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells. J Cell Biochem 2009;106:682-92. [PMID: 19160421 DOI: 10.1002/jcb.22065] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 5.6] [Reference Citation Analysis]
104 Zhang J, Chen YH, Lu Q. Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy. Future Oncol 2010;6:587-603. [PMID: 20373871 DOI: 10.2217/fon.10.15] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
105 Aktas CC, Zeybek ND, Piskin AK. In vitro effects of phenytoin and DAPT on MDA-MB-231 breast cancer cells. Acta Biochim Biophys Sin (Shanghai) 2015;47:680-6. [PMID: 26206582 DOI: 10.1093/abbs/gmv066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
106 Veeraraghavalu K, Pett M, Kumar RV, Nair P, Rangarajan A, Stanley MA, Krishna S. Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation. J Virol 2004;78:8687-700. [PMID: 15280477 DOI: 10.1128/JVI.78.16.8687-8700.2004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
107 Kuphal S, Wallner S, Schimanski CC, Bataille F, Hofer P, Strand S, Strand D, Bosserhoff AK. Expression of Hugl-1 is strongly reduced in malignant melanoma. Oncogene. 2006;25:103-110. [PMID: 16170365 DOI: 10.1038/sj.onc.1209008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 67] [Article Influence: 3.3] [Reference Citation Analysis]
108 Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells. 2010;28:5-16. [PMID: 19904829 DOI: 10.1002/stem.254] [Cited by in Crossref: 80] [Cited by in F6Publishing: 289] [Article Influence: 6.7] [Reference Citation Analysis]
109 Kobayashi N, Navarro-Alvarez N, Soto-Gutierrez A, Kawamoto H, Kondo Y, Yamatsuji T, Shirakawa Y, Naomoto Y, Tanaka N. Cancer stem cell research: current situation and problems. Cell Transplant 2008;17:19-25. [PMID: 18468231 DOI: 10.3727/000000008783906982] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
110 Takebe N, Nguyen D, Yang SX. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther. 2014;141:140-149. [PMID: 24076266 DOI: 10.1016/j.pharmthera.2013.09.005] [Cited by in Crossref: 240] [Cited by in F6Publishing: 229] [Article Influence: 26.7] [Reference Citation Analysis]
111 Kang S, Yang C, Luo R. Induction of CCL2 by siMAML1 through upregulation of TweakR in melanoma cells. Biochem Biophys Res Commun 2008;372:629-33. [PMID: 18503747 DOI: 10.1016/j.bbrc.2008.05.079] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
112 Deonarain MP, Kousparou CA, Epenetos AA. Antibodies targeting cancer stem cells: a new paradigm in immunotherapy? MAbs. 2009;1:12-25. [PMID: 20046569 DOI: 10.4161/mabs.1.1.7347] [Cited by in Crossref: 107] [Cited by in F6Publishing: 97] [Article Influence: 8.9] [Reference Citation Analysis]
113 Li JY, Huang WX, Zhou X, Chen J, Li Z. Numb inhibits epithelial-mesenchymal transition via RBP-Jκ-dependent Notch1/PTEN/FAK signaling pathway in tongue cancer. BMC Cancer 2019;19:391. [PMID: 31023264 DOI: 10.1186/s12885-019-5605-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
114 Movahedan A, Majdi M, Afsharkhamseh N, Sagha HM, Saadat NS, Shalileh K, Milani BY, Ying H, Djalilian AR. Notch inhibition during corneal epithelial wound healing promotes migration. Invest Ophthalmol Vis Sci 2012;53:7476-83. [PMID: 23049092 DOI: 10.1167/iovs.12-10735] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
115 Koo T, Cho BJ, Kim DH, Park JM, Choi EJ, Kim HH, Lee DJ, Kim IA. MicroRNA-200c increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. Oncotarget 2017;8:65457-68. [PMID: 29029445 DOI: 10.18632/oncotarget.18924] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
116 Sun S, Schiller JH, Spinola M, Minna JD. New molecularly targeted therapies for lung cancer. J Clin Invest 2007;117:2740-50. [PMID: 17909619 DOI: 10.1172/JCI31809] [Cited by in Crossref: 144] [Cited by in F6Publishing: 88] [Article Influence: 9.6] [Reference Citation Analysis]
117 Pindiprolu SKSS, Krishnamurthy PT, Dev C, Chintamaneni PK. DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer. Chem Phys Lipids 2021;235:105033. [PMID: 33385372 DOI: 10.1016/j.chemphyslip.2020.105033] [Reference Citation Analysis]
118 Baker AT, Zlobin A, Osipo C. Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer. Front Oncol 2014;4:360. [PMID: 25566499 DOI: 10.3389/fonc.2014.00360] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
119 Tohda S, Kogoshi H, Murakami N, Sakano S, Nara N. Diverse effects of the Notch ligands Jagged1 and Delta1 on the growth and differentiation of primary acute myeloblastic leukemia cells. Exp Hematol 2005;33:558-63. [PMID: 15850833 DOI: 10.1016/j.exphem.2005.01.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
120 Papagerakis S, Pannone G, Zheng L, About I, Taqi N, Nguyen NP, Matossian M, McAlpin B, Santoro A, McHugh J, Prince ME, Papagerakis P. Oral epithelial stem cells - implications in normal development and cancer metastasis. Exp Cell Res 2014;325:111-29. [PMID: 24803391 DOI: 10.1016/j.yexcr.2014.04.021] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
121 Bianco C, Strizzi L, Normanno N, Khan N, Salomon DS. Cripto-1: an oncofetal gene with many faces. Curr Top Dev Biol 2005;67:85-133. [PMID: 15949532 DOI: 10.1016/S0070-2153(05)67003-2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
122 Acharyya S, Sharma SM, Cheng AS, Ladner KJ, He W, Kline W, Wang H, Ostrowski MC, Huang TH, Guttridge DC. TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in duchenne muscular dystrophy. PLoS One 2010;5:e12479. [PMID: 20814569 DOI: 10.1371/journal.pone.0012479] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 7.0] [Reference Citation Analysis]
123 Siar CH, Nagatsuka H, Chuah KS, Rivera RS, Nakano K, Ng KH, Kawakami T. Notch4 overexpression in ameloblastoma correlates with the solid/multicystic phenotype. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2010;110:224-33. [DOI: 10.1016/j.tripleo.2010.03.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
124 Tohda S, Sato T, Kogoshi H, Fu L, Sakano S, Nara N. Establishment of a novel B-cell lymphoma cell line with suppressed growth by gamma-secretase inhibitors. Leuk Res 2006;30:1385-90. [PMID: 16780947 DOI: 10.1016/j.leukres.2006.05.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
125 Zou B, Wang H, Liu Y, Qi P, Lei T, Sun M, Wang Y. Mangiferin induces apoptosis in human ovarian adenocarcinoma OVCAR3 cells via the regulation of Notch3. Oncol Rep 2017;38:1431-41. [PMID: 28714011 DOI: 10.3892/or.2017.5814] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
126 Kakarala M, Wicha MS. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol. 2008;26:2813-2820. [PMID: 18539959 DOI: 10.1200/jco.2008.16.3931] [Cited by in Crossref: 282] [Cited by in F6Publishing: 165] [Article Influence: 20.1] [Reference Citation Analysis]
127 Gharaibeh L, Elmadany N, Alwosaibai K, Alshaer W. Notch1 in Cancer Therapy: Possible Clinical Implications and Challenges. Mol Pharmacol 2020;98:559-76. [PMID: 32913140 DOI: 10.1124/molpharm.120.000006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
128 Suh SS, Lee SG, Youn UJ, Han SJ, Kim IC, Kim S. Comprehensive Expression Profiling and Functional Network Analysis of Porphyra-334, One Mycosporine-Like Amino Acid (MAA), in Human Keratinocyte Exposed with UV-radiation. Mar Drugs 2017;15:E196. [PMID: 28672785 DOI: 10.3390/md15070196] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
129 Kanamori M, Kawaguchi T, Nigro JM, Feuerstein BG, Berger MS, Miele L, Pieper RO. Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg. 2007;106:417-427. [PMID: 17367064 DOI: 10.3171/jns.2007.106.3.417] [Cited by in Crossref: 138] [Cited by in F6Publishing: 132] [Article Influence: 9.2] [Reference Citation Analysis]
130 Panelos J, Tarantini F, Paglierani M, Di Serio C, Maio V, Pellerito S, Pimpinelli N, Santucci M, Massi D. Photoexposition discriminates Notch 1 expression in human cutaneous squamous cell carcinoma. Mod Pathol 2008;21:316-25. [PMID: 18192969 DOI: 10.1038/modpathol.3801007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
131 Li X, Shen L, Shang X, Liu W. Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway. PLoS One 2015;10:e0132813. [PMID: 26207919 DOI: 10.1371/journal.pone.0132813] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
132 Qiu K, Ma C, Lu L, Wang J, Chen B, Mao H, Wang Y, Wang H. DAPT suppresses proliferation and migration of hepatocellular carcinoma by regulating the extracellular matrix and inhibiting the Hes1/PTEN/AKT/mTOR signaling pathway. J Gastrointest Oncol 2021;12:1101-16. [PMID: 34295560 DOI: 10.21037/jgo-21-235] [Reference Citation Analysis]
133 Fu L, Kogoshi H, Nara N, Tohda S. NOTCH1 mutations are rare in acute myeloid leukemia. Leukemia & Lymphoma 2009;47:2400-3. [DOI: 10.1080/10428190600773339] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
134 Reedijk M. Notch Signaling and Breast Cancer. In: Reichrath J, Reichrath S, editors. Notch Signaling in Embryology and Cancer. New York: Springer US; 2012. pp. 241-57. [DOI: 10.1007/978-1-4614-0899-4_18] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
135 Ferretti E, Tosi E, Po A, Scipioni A, Morisi R, Espinola MS, Russo D, Durante C, Schlumberger M, Screpanti I, Filetti S, Gulino A. Notch Signaling Is Involved in Expression of Thyrocyte Differentiation Markers and Is Down-Regulated in Thyroid Tumors. The Journal of Clinical Endocrinology & Metabolism 2008;93:4080-7. [DOI: 10.1210/jc.2008-0528] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
136 Nandi A, Chakrabarti R. The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance. Genes Dev 2020;34:1422-38. [PMID: 33872192 DOI: 10.1101/gad.342287.120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
137 Gilyazova IR, Klimentova EA, Bulygin KV, Izmailov AA, Bermisheva MA, Galimova EF, Safiullin RI, Galimov SN, Pavlov VN, Khusnutdinova EK. MicroRNA-200 family expression analysis in metastatic clear cell renal cell carcinoma patients. Cancer Gene Ther 2020;27:768-72. [PMID: 31680118 DOI: 10.1038/s41417-019-0149-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
138 Kang S, Xie J, Miao J, Li R, Liao W, Luo R. A knockdown of Maml1 that results in melanoma cell senescence promotes an innate and adaptive immune response. Cancer Immunol Immunother. 2013;62:183-190. [PMID: 22864395 DOI: 10.1007/s00262-012-1318-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
139 Cruickshank MN, Ulgiati D. The role of notch signaling in the development of a normal B‐cell repertoire. Immunol Cell Biol 2010;88:117-24. [DOI: 10.1038/icb.2009.73] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
140 Adeola HA, Papagerakis S, Papagerakis P. Systems Biology Approaches and Precision Oral Health: A Circadian Clock Perspective. Front Physiol 2019;10:399. [PMID: 31040792 DOI: 10.3389/fphys.2019.00399] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
141 Wang N, Li MY, Liu Y, Yu J, Ren J, Zheng Z, Wang S, Yang S, Yang SL, Liu LP, Hu BG, Chong CC, Merchant JL, Lai PB, Chen GG. ZBP-89 negatively regulates self-renewal of liver cancer stem cells via suppression of Notch1 signaling pathway. Cancer Lett 2020;472:70-80. [PMID: 31874246 DOI: 10.1016/j.canlet.2019.12.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
142 Shih IeM, Davidson B. Pathogenesis of ovarian cancer: clues from selected overexpressed genes. Future Oncol 2009;5:1641-57. [PMID: 20001801 DOI: 10.2217/fon.09.126] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
143 Cheng H, Zhu H, Cao M, Lu C, Bao S, Pan Y. HtrA1 suppresses the growth of pancreatic cancer cells by modulating Notch-1 expression. Braz J Med Biol Res 2018;52:e7718. [PMID: 30484491 DOI: 10.1590/1414-431X20187718] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
144 Dang L, Fan X, Chaudhry A, Wang M, Gaiano N, Eberhart CG. Notch3 signaling initiates choroid plexus tumor formation. Oncogene 2006;25:487-91. [PMID: 16186803 DOI: 10.1038/sj.onc.1209074] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.2] [Reference Citation Analysis]
145 Silva F, Félix A, Serpa J. Functional redundancy of the Notch pathway in ovarian cancer cell lines. Oncol Lett 2016;12:2686-91. [PMID: 27698843 DOI: 10.3892/ol.2016.4959] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
146 Bhat KM, Maddodi N, Shashikant C, Setaluri V. Transcriptional regulation of human MAP2 gene in melanoma: role of neuronal bHLH factors and Notch1 signaling. Nucleic Acids Res 2006;34:3819-32. [PMID: 16916793 DOI: 10.1093/nar/gkl476] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
147 Manfè V, Biskup E, Rosbjerg A, Kamstrup M, Skov AG, Lerche CM, Lauenborg BT, Odum N, Gniadecki R. miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma. PLoS One 2012;7:e29541. [PMID: 22235305 DOI: 10.1371/journal.pone.0029541] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 7.3] [Reference Citation Analysis]
148 Zhu TS, Costello MA, Talsma CE, Flack CG, Crowley JG, Hamm LL, He X, Hervey-Jumper SL, Heth JA, Muraszko KM. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res. 2011;71:6061-6072. [PMID: 21788346 DOI: 10.1158/0008-5472.can-10-4269] [Cited by in Crossref: 230] [Cited by in F6Publishing: 147] [Article Influence: 20.9] [Reference Citation Analysis]
149 Yoon HA, Noh MH, Kim BG, Han JS, Jang JS, Choi SR, Jeong JS, Chun JH. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma. World J Gastroenterol 2011; 17(35): 4023-4030 [PMID: 22046092 DOI: 10.3748/wjg.v17.i35.4023] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
150 Rooney P, Connolly M, Gao W, McCormick J, Biniecka M, Sullivan O, Kirby B, Sweeney C, Molloy E, Markham T, Fearon U, Veale DJ. Notch-1 mediates endothelial cell activation and invasion in psoriasis. Exp Dermatol 2014;23:113-8. [PMID: 24330353 DOI: 10.1111/exd.12306] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
151 Cummins TD, Mendenhall MD, Lowry MN, Korte EA, Barati MT, Khundmiri SJ, Salyer SA, Klein JB, Powell DW. Elongin C is a mediator of Notch4 activity in human renal tubule cells. Biochim Biophys Acta 2011;1814:1748-57. [PMID: 22001063 DOI: 10.1016/j.bbapap.2011.09.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
152 Biunno I, Cattaneo M, Orlandi R, Canton C, Biagiotti L, Ferrero S, Barberis M, Pupa SM, Scarpa A, Ménard S. SEL1L a multifaceted protein playing a role in tumor progression. J Cell Physiol 2006;208:23-38. [PMID: 16331677 DOI: 10.1002/jcp.20574] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
153 Huang KH, Sung IC, Fang WL, Chi CW, Yeh TS, Lee HC, Yin PH, Li AF, Wu CW, Shyr YM, Yang MH. Correlation between HGF/c-Met and Notch1 signaling pathways in human gastric cancer cells. Oncol Rep 2018;40:294-302. [PMID: 29781036 DOI: 10.3892/or.2018.6447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
154 Jia X, Wang W, Xu Z, Wang S, Wang T, Wang M, Wu M. A humanized anti-DLL4 antibody promotes dysfunctional angiogenesis and inhibits breast tumor growth. Sci Rep 2016;6:27985. [PMID: 27301650 DOI: 10.1038/srep27985] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
155 Ostroukhova M, Qi Z, Oriss TB, Dixon-McCarthy B, Ray P, Ray A. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J Clin Invest. 2006;116:996-1004. [PMID: 16543950 DOI: 10.1172/jci26490] [Cited by in Crossref: 135] [Cited by in F6Publishing: 69] [Article Influence: 8.4] [Reference Citation Analysis]
156 Ma D, Dong X, Zang S, Ma R, Zhao P, Guo D, Dai J, Chen F, Ye J, Ji C. Aberrant expression and clinical correlation of Notch signaling molecules in breast cancer of Chinese population. Asia Pac J Clin Oncol 2011;7:385-91. [PMID: 22151989 DOI: 10.1111/j.1743-7563.2011.01433.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
157 Bischoff J. Targeted Therapy of Breast Cancer - New Insights and Perspectives. Breast Care (Basel) 2008;3:395-8. [PMID: 21048909 DOI: 10.1159/000177226] [Reference Citation Analysis]
158 Song LL, Miele L. Cancer stem cells--an old idea that's new again: implications for the diagnosis and treatment of breast cancer. Expert Opin Biol Ther 2007;7:431-8. [PMID: 17373895 DOI: 10.1517/14712598.7.4.431] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
159 Jang MS, Miao H, Carlesso N, Shelly L, Zlobin A, Darack N, Qin JZ, Nickoloff BJ, Miele L. Notch-1 regulates cell death independently of differentiation in murine erythroleukemia cells through multiple apoptosis and cell cycle pathways. J Cell Physiol 2004;199:418-33. [PMID: 15095289 DOI: 10.1002/jcp.10467] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 2.9] [Reference Citation Analysis]
160 González Moles MÁ. Cancer Stem Cells—Biopathology with Reference to Head and Neck Cancers. In: Warnakulasuriya S, Khan Z, editors. Squamous cell Carcinoma. Dordrecht: Springer Netherlands; 2017. pp. 37-57. [DOI: 10.1007/978-94-024-1084-6_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
161 Bolós V, Grego-Bessa J, de la Pompa JL. Notch signaling in development and cancer. Endocr Rev. 2007;28:339-363. [PMID: 17409286 DOI: 10.1210/er.2006-0046] [Cited by in Crossref: 369] [Cited by in F6Publishing: 349] [Article Influence: 24.6] [Reference Citation Analysis]
162 Li Y, Burns JA, Cheney CA, Zhang N, Vitelli S, Wang F, Bett A, Chastain M, Audoly LP, Zhang ZQ. Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies. Biologics 2010;4:163-71. [PMID: 20631820 DOI: 10.2147/btt.s11021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 0.1] [Reference Citation Analysis]
163 Suwanjunee S, Wongchana W, Palaga T. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling. Anticancer Drugs. 2008;19:477-486. [PMID: 18418214 DOI: 10.1097/cad.0b013e3282fc6cdd] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
164 Silveira NJ, Varuzza L, Machado-Lima A, Lauretto MS, Pinheiro DG, Rodrigues RV, Severino P, Nobrega FG, Silva WA Jr, de B Pereira CA, Tajara EH; Head and Neck Genome Project GENCAPO. Searching for molecular markers in head and neck squamous cell carcinomas (HNSCC) by statistical and bioinformatic analysis of larynx-derived SAGE libraries. BMC Med Genomics 2008;1:56. [PMID: 19014460 DOI: 10.1186/1755-8794-1-56] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
165 Akiyoshi T, Nakamura M, Yanai K, Nagai S, Wada J, Koga K, Nakashima H, Sato N, Tanaka M, Katano M. Gamma-secretase inhibitors enhance taxane-induced mitotic arrest and apoptosis in colon cancer cells. Gastroenterology 2008;134:131-44. [PMID: 18166351 DOI: 10.1053/j.gastro.2007.10.008] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 3.7] [Reference Citation Analysis]
166 D’Angelo RC, Wicha MS. Stem cells in normal development and cancer. Prog Mol Biol Transl Sci. 2010;95:113-158. [PMID: 21075331 DOI: 10.1016/b978-0-12-385071-3.00006-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
167 Moretti E, Favero G, Rodella LF, Rezzani R. Melatonin's Antineoplastic Potential Against Glioblastoma. Cells 2020;9:E599. [PMID: 32138190 DOI: 10.3390/cells9030599] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
168 Miao Z, Miao Y, Lin Y, Lu X. Overexpression of the Notch3 receptor in non-functioning pituitary tumours. Journal of Clinical Neuroscience 2012;19:107-10. [DOI: 10.1016/j.jocn.2011.07.029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
169 Niessen K, Karsan A. Notch signaling in the developing cardiovascular system. American Journal of Physiology-Cell Physiology 2007;293:C1-C11. [DOI: 10.1152/ajpcell.00415.2006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
170 Margareto J, Leis O, Larrarte E, Idoate MA, Carrasco A, Lafuente JV. Gene expression profiling of human gliomas reveals differences between GBM and LGA related to energy metabolism and notch signaling pathways. J Mol Neurosci 2007;32:53-63. [PMID: 17873288 DOI: 10.1007/s12031-007-0008-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
171 Sayed SI, Dwivedi RC, Katna R, Garg A, Pathak KA, Nutting CM, Rhys-Evans P, Harrington KJ, Kazi R. Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. Oral Oncol. 2011;47:237-243. [PMID: 21382740 DOI: 10.1016/j.oraloncology.2011.02.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
172 Roesch A, Mueller AM, Stempfl T, Moehle C, Landthaler M, Vogt T. RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells. Int J Cancer 2008;122:1047-57. [PMID: 17973255 DOI: 10.1002/ijc.23211] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 3.6] [Reference Citation Analysis]
173 Xu P, Yu S, Jiang R, Kang C, Wang G, Jiang H, Pu P. Differential expression of Notch family members in astrocytomas and medulloblastomas. Pathol Oncol Res 2009;15:703-10. [PMID: 19424825 DOI: 10.1007/s12253-009-9173-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
174 Keller PC 2nd, Tomita T, Hayashi I, Chandu D, Weber JD, Cistola DP, Kopan R. A faster migrating variant masquerades as NICD when performing in vitro gamma-secretase assays with bacterially expressed Notch substrates. Biochemistry 2006;45:5351-8. [PMID: 16618124 DOI: 10.1021/bi052228a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
175 Peng T, Zhou Y, Li J, Li J, Wan W, Jia Y. Detection of Delta-like 1 ligand for the diagnosis of tuberculous meningitis: An effective and rapid diagnostic method. J Int Med Res 2014;42:728-36. [PMID: 24651996 DOI: 10.1177/0300060513498669] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
176 Rohrbeck A, Borlak J. Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1. PLoS One 2009;4:e7315. [PMID: 19812696 DOI: 10.1371/journal.pone.0007315] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
177 Schwarzmeier J, Hubmann R, Düchler M, Jäger U, Shehata M. Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemia. Leukemia & Lymphoma 2009;46:157-65. [DOI: 10.1080/10428190400010742] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
178 Schouwey K, Aydin IT, Radtke F, Beermann F. RBP-Jκ-dependent Notch signaling enhances retinal pigment epithelial cell proliferation in transgenic mice. Oncogene 2011;30:313-22. [DOI: 10.1038/onc.2010.428] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
179 Laranjeira AB, Yang SX. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic. Expert Opin Drug Discov 2016;11:1071-80. [PMID: 27626707 DOI: 10.1080/17460441.2016.1236785] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
180 Nielsen DL, Andersson M, Andersen JL, Kamby C. Antiangiogenic therapy for breast cancer. Breast Cancer Res 2010;12:209. [PMID: 21067536 DOI: 10.1186/bcr2642] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
181 Bolós V, Blanco M, Medina V, Aparicio G, Díaz-Prado S, Grande E. Notch signalling in cancer stem cells. Clin Transl Oncol. 2009;11:11-19. [PMID: 19155199 DOI: 10.1007/s12094-009-0305-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 4.6] [Reference Citation Analysis]
182 Ishimoto T, Sawayama H, Sugihara H, Baba H. Interaction between gastric cancer stem cells and the tumor microenvironment. J Gastroenterol 2014;49:1111-20. [DOI: 10.1007/s00535-014-0952-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
183 Shi YC, Zhao H, Yin C, Zeng X, Zhang Q, Xu WP, Wei J, Chen F, Xie WF. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades. Dig Liver Dis 2013;45:844-51. [PMID: 23816696 DOI: 10.1016/j.dld.2013.03.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
184 Hughes DP. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize. Cancer Treat Res 2009;152:479-96. [PMID: 20213410 DOI: 10.1007/978-1-4419-0284-9_28] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 5.7] [Reference Citation Analysis]
185 Ramdass B, Maliekal TT, Lakshmi S, Rehman M, Rema P, Nair P, Mukherjee G, Reddy B, Krishna S, Radhakrishna Pillai M. Coexpression of Notch1 and NF-κB signaling pathway components in human cervical cancer progression. Gynecologic Oncology 2007;104:352-61. [DOI: 10.1016/j.ygyno.2006.08.054] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 4.8] [Reference Citation Analysis]
186 Eilon T, Barash I. Different gene-expression profiles for the poorly differentiated carcinoma and the highly differentiated papillary adenocarcinoma in mammary glands support distinct metabolic pathways. BMC Cancer 2008;8:270. [PMID: 18811984 DOI: 10.1186/1471-2407-8-270] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
187 Gottardo NG, Gajjar A. Current therapy for medulloblastoma. Curr Treat Options Neurol 2006;8:319-34. [DOI: 10.1007/s11940-006-0022-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
188 Hsu MY, Yang MH, Schnegg CI, Hwang S, Ryu B, Alani RM. Notch3 signaling-mediated melanoma-endothelial crosstalk regulates melanoma stem-like cell homeostasis and niche morphogenesis. Lab Invest 2017;97:725-36. [PMID: 28165469 DOI: 10.1038/labinvest.2017.1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
189 Bizama C, García P, Espinoza JA, Weber H, Leal P, Nervi B, Roa JC. Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy. Cancer Treat Rev. 2015;41:222-234. [PMID: 25639632 DOI: 10.1016/j.ctrv.2015.01.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
190 Masià A, Almazán-Moga A, Velasco P, Reventós J, Torán N, Sánchez de Toledo J, Roma J, Gallego S. Notch-mediated induction of N-cadherin and α9-integrin confers higher invasive phenotype on rhabdomyosarcoma cells. Br J Cancer 2012;107:1374-83. [PMID: 22976797 DOI: 10.1038/bjc.2012.411] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
191 Santos L, León-Galván MF, Marino-Marmolejo EN, Barba de la Rosa AP, De León Rodríguez A, González-Amaro R, Guevara-González RG. Identification of differential expressed transcripts in cervical cancer of Mexican patients. Tumour Biol 2011;32:561-8. [PMID: 21225484 DOI: 10.1007/s13277-010-0151-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
192 Li J, Li J, Jia Y. Levels of soluble delta-like ligand 1 in the serum and cerebrospinal fluid of tuberculous meningitis patients. Neural Regen Res 2012;7:874-8. [PMID: 25737717 DOI: 10.3969/j.issn.1673-5374.2012.11.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
193 Nguyen D, Rubinstein L, Takebe N, Miele L, Tomaszewski JE, Ivy P, Doroshow JH, Yang SX. Notch1 phenotype and clinical stage progression in non-small cell lung cancer. J Hematol Oncol 2015;8:9. [PMID: 25653136 DOI: 10.1186/s13045-014-0104-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
194 Rajasekhar VK, Holland EC. Postgenomic global analysis of translational control induced by oncogenic signaling. Oncogene 2004;23:3248-64. [DOI: 10.1038/sj.onc.1207546] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 3.4] [Reference Citation Analysis]
195 Xu Y, Zhu F, Xu S, Liu L. Anti-tumor effect of the extract from qingyihuaji formula on pancreatic cancer by down-regulating Notch-4 and Jagged-1. J Tradit Chin Med 2015;35:77-83. [PMID: 25842732 DOI: 10.1016/s0254-6272(15)30012-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
196 Aleksic T, Feller SM. Gamma-secretase inhibition combined with platinum compounds enhances cell death in a large subset of colorectal cancer cells. Cell Commun Signal 2008;6:8. [PMID: 18950493 DOI: 10.1186/1478-811X-6-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]